This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n6http://linked.opendata.cz/resource/drugbank/drug/DB07791/identifier/pdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07791/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07791/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07791/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07791
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB07791 n13:DB07791
dcterms:title
4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE
adms:identifier
n6:FRV n7:24901723 n8:DB07791 n9:99444262
n3:IUPAC-Name
n4:271B3F8B-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B3F91-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B3F90-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B3F8D-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B3F8E-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B3F8F-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B3F89-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B3F87-363D-11E5-9242-09173F13E4C5 n4:271B3F8A-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B3F88-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B3F97-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B3F98-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B3F92-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B3F93-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B3F95-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B3F94-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B3F96-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B3F9D-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B3F9F-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B3FA0-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B3F9C-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B3F9B-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B3F9E-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B3F8C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B3F99-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B3F9A-363D-11E5-9242-09173F13E4C5